第一单位：
Department of Gynecologic Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, CIBERONC, Barcelona, Spain. Electronic address: agil@vhebron.net.
作者：
Antonio,Gil-Moreno [1]
;
Lorena,Alonso-Alconada [2]
;
Berta,Díaz-Feijoo [3]
;
Santiago,Domingo [4]
;
Ana,Vilar [5]
;
Alicia,Hernández [6]
;
Juan,Gilabert [7]
;
Antoni,Llueca [8]
;
Aureli,Torné [9]
;
Javier,de Santiago [10]
;
Melchor,Carbonell-Socias [3]
;
Víctor,Lago [4]
;
Efigenia,Arias [5]
;
Victoria,Sampayo [5]
;
Jaime,Siegrist [6]
;
Anca,Chipirliu [7]
;
Jose Luis,Sánchez-Iglesias [3]
;
Assumpció,Pérez-Benavente [3]
;
Pablo,Padilla-Iserte [4]
;
Maria,Santacana [11]
;
Xavier,Matias-Guiu [11]
;
Miguel,Abal [12]
;
Rafael,Lopez-Lopez [13]
作者单位：
Department of Gynecologic Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, CIBERONC, Barcelona, Spain. Electronic address: agil@vhebron.net.
[1]
Nasasbiotech, S.L., A Coruña, Spain.
[2]
Department of Gynecologic Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Biomedical Research Group in Gynecology, Vall Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, CIBERONC, Barcelona, Spain.
[3]
Department of Gynecology Oncology, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
[4]
Department of Gynecology, University Hospital of Santiago de Compostela, Spain.
[5]
Department of Gynecology, University Hospital La Paz, Madrid, Spain.
[6]
Department of Obstetrics and Gynecology, Hospital General Universitario de Valencia, Universidad de Valencia, Valencia, Spain.
[7]
Department of Obstetrics and Gynecology, Hospital General Universitari de Castelló, Castelló de la Plana, Spain.
[8]
Institute Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
[9]
Department of Gynecology, MD Anderson Cancer Center, Madrid, Spain.
[10]
Department of Pathology and Molecular Genetics and Research Laboratory, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLleida, CIBERONC, Lleida, Spain.
[11]
Nasasbiotech, S.L., A Coruña, Spain; Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), CIBERONC, Santiago de Compostela, Spain.
[12]
Translational Medical Oncology Group (Oncomet), Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela (SERGAS), CIBERONC, Santiago de Compostela, Spain. Electronic address: rafael.lopez.lopez@sergas.es.
[13]
DOI
10.1016/j.ygyno.2021.03.022
PMID
33795131
发布时间
2022-01-03
换一批
